Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses-Reference-Cited by-同舟云学术

Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses

Published:2021-10-27 Issue:3 Volume:78 Page:311-338
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Lima Tácio de Mendonça,Visacri Marília Berlofa,Aguiar Patricia Melo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-021-03216-8.pdf

Reference67 articles.

1. Brigitta B (2002) Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci 4(1):7–20

2. Hasler G (2010) Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 9(3):155–161

3. World Health Organization (2017) Depression and other common mental disorders: global health estimates. World Health Organization CC BY-NC-SA 3.0 IGO

4. Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC (2015) The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry 76:155–162

5. Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N (2013) Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 11:129

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect and mechanism of low-dose esketamine in neuropathic pain-related depression-like behavior in rats;Brain Research;2024-11

2. KETAMINE: Neural- and network-level changes;Neuroscience;2024-11

3. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes;The Canadian Journal of Psychiatry;2024-05-06

4. Comparison of Effects of Propofol Combined with Different Doses of Esketamine for ECT in the Treatment of Depression: A Randomized Controlled Trial Protocol;Neuropsychiatric Disease and Treatment;2024-05

5. The Relationship Between Perioperative Use of Esketamine and Postpartum Depression Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Neuropsychiatric Disease and Treatment;2024-05